Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budenofalk for prevention of acute radiation proctitis
NCT00828230Phase 2Terminated
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Sep 2008
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in radiation proctitis, sponsored by Dr. Falk Pharma GmbH. Started Sep 2008; status: terminated.
02
Drugs
budesonide
03
Conditions
radiation proctitis
Beyond the preview
Go deeper on NCT00828230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828230.